Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lock-Urelumab - PrecisemAb

Next Previous
Drug Profile

Lock-Urelumab - PrecisemAb

Alternative Names: Lock-4-1-BB; Lock-anti-4-1BB antibody

Latest Information Update: 22 Jul 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator PrecisemAb
  • Class Antineoplastics; Gene therapies; Immunotherapies; Monoclonal antibodies
  • Mechanism of Action Antibody-dependent cell cytotoxicity; CD137 antigen antagonists; T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Cancer; Lymphoma

Most Recent Events

  • 22 Apr 2026 Preclinical trials in Cancer in Taiwan prior to April 2026 (Parenteral)
  • 22 Apr 2026 Pharmacodynamics and adverse events data from a preclinical trial in Cancer presented at the 117th Annual Meeting of the American Association for Cancer Research (AACR-2026)
  • 03 Aug 2022 Lock-anti-4-1BB antibody - PrecisemAb is available for licensing as of 03 Aug 2022. https://www.precisemab.com.tw/Partners

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top